Evidence map›Paper›PMID 34406504›Full record

Observational studyEuropean journal of pediatrics2022

COVID-19 in children: clinical and epidemiological spectrum in the community.

César García-Vera, Sandra Castejón-Ramírez, Elena Laín Miranda, Rebeca Hernández Abadía, María García Ventura, Elena Borque Navarro, Patricia Rubio Sánchez, Álvaro Baeta Ruiz, José María Mengual Gil

Erratum issuedAbstract readObservational Study
In one paragraph

Observational study in European journal of pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Observational
  15. [COVID-19 clinical features in primary care: COVIDPAP study].Anales de pediatria (Barcelona, Spain : 2003) · 2022
    Article
  16. Review
  17. Article
  18. COVID-19 in pediatric patient.European journal of pediatrics · 2022
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

César García-VeraPrimary Health Care Center "José Ramón Muñoz Fernández", Zaragoza, Spain. cgarciavera@gmail.com.ORCID http://orcid.org/0000-0003-3017-969X
Sandra Castejón-RamírezHospital Materno-Infantil Miguel Servet, Zaragoza, Spain.
Elena Laín MirandaPublic Health Technician in the Health Region II of Zaragoza, Zaragoza, Spain.
Rebeca Hernández AbadíaHospital Materno-Infantil Miguel Servet, Zaragoza, Spain.
María García VenturaPrimary Health Care Center "Valdespartera", Zaragoza, Spain.
Elena Borque NavarroHospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Patricia Rubio SánchezHospital Materno-Infantil Miguel Servet, Zaragoza, Spain.
Álvaro Baeta RuizHospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
José María Mengual GilPrimary Health Care Center "Delicias Sur", Zaragoza, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most publications on pediatric COVID-19 in Spain were performed at the beginning of the pandemic when some diagnostic tools were not widely available. This study aims to show the real spectrum of the infection based on wide detection of cases due to symptoms and contact tracing. A descriptive and analytical observational study was performed including pediatric cases (0 to 14 years) from the region of Aragón between May 12 and October 31, 2020. Diagnostics was by PCR detection of viral RNA, rapid antigen detection test, or positive IgG serology. There were 5933 positive children included. Of them, 49.03% were women. The mean age was 7.53 ± 4.28 years. The source of infection could not be determined in 17.8% of cases. As for the rest, was determined to be within the family environment in 67.8%. The percentage of asymptomatic patients was 50.3%. Among symptomatic patients, fever (58.1%) and cough (46.7%) were the most frequent symptoms. Hospitalization was required in 0.52% of infected, intensive care unit admission was on 0.05%, and there was one death (0.02%). Children under the age of one presented some symptoms more frequently (71.6% vs 48.5%; OR 2.68; 95% CI 2.08 to 3.45; p < 0.001) and required more hospitalizations (3.9% vs 0.34%; OR 11.52; 95% CI 5.65 to 23.52; p < 0.001).Conclusion: In our environment, SARS-CoV-2 infection is like other mild respiratory viral infections in the population under the age of 15. The contagion occurs mainly in the family environment, the number of asymptomatic is high, being the symptoms mild and the complications very infrequent. What is Known: • Pediatric infection produced by SARS-CoV-2 has manifested as a mild disease in relation to adult age, although with higher affectation at the youngest ages. • Nearly all studies on epidemiology and clinical spectrum of the disease were conducted with patients diagnosed at the beginning of the pandemic. By then, diagnostic tools were only available in hospitals and in emergency units. What is New: • Once diagnostic means were available in primary care medicine and were used not only for the diagnosis of clinical symptoms of the patient, but for the tracing of case contacts, a much more precise approach to the epidemiology and clinical manifestations of the disease was allowed, as described in this study.

Indexed as

COVID-19AdultChildChild, PreschoolCoughFemaleFeverHumansPandemicsSARS-CoV-2Asymptomatic diseasesChildCOVID-19 epidemiologyPathologyRetrospective studies

Identifiers

PMID34406504
PMCPMC8371417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.